USPTO serial 79344067
NEWLUX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 26, 2023
- Examiner
- BRYANT, ALEXANDRIA N
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NEWLUX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark J. Liss
Mark J. Liss Leydig, Voit & Mayer, Ltd.Two Prudential Plaza, 180 N. Stetson AveSuite 4900Chicago, IL 60601Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical agents affecting sensory organs; muscle relaxants; preparations for the treatment of muscle fatigue;pharmaceutical agents affecting peripheral nervous system; vaccines; pharmaceuticals containing botulinum toxin for medical use for use in treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, neuropathy pain and pelvic pain; bacteria poisons;pharmacological preparations for skin care; chemico-pharmaceutical preparations for skin care, skin wounds, prevention of migraines; pharmaceutical agents for epidermis; biological preparations for medical or veterinary purposes being bacterial and bacteriological preparations; medicated lotions for skin, sunburn, face, body; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient; medical infusions for treating migraine headaches, excessive sweating, urinary incontinence; injectable dermal fillers; implantable medicines being medicinal infusions, injectable gels, injectable pharmaceuticals for use in the treatment of anaphylactic reactions, migraine headaches, urinary incontinence, neurological disorders and muscle dystonia; pharmaceutical preparations acting on the central nervous system; pain relief medication; dermatological pharmaceutical products; pharmaceutical preparations for treating skin disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 23, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 27, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 27, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 26, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 2, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 26, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 26, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 13, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 13, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 10, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 10, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 10, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 20, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 20, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 20, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 1, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 8, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 8, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 8, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 29, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 3, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 3, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 7, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 6, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 28, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 12, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 8, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 7, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |